News | News By Subject | News by Disease News By Date | Search News

Chronic obstructive pulmonary disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
7 PDUFA Dates to Mark on Your Calendars for September     9/7/2017
GlaxoSmithKline (GSK) Terminates Development of Losmapimod for COPD     10/26/2016
Theravance Biopharma (TBPH) Touts Significant Data from Pivotal Phase III FULFIL Study     9/8/2016
AstraZeneca PLC (AZN) Announces Positive Top-Line Data From Two Phase III SYMBICORT Studies     8/10/2016
Verona Pharma (VRP.L) Rakes in $63.3 Million to Help Progress COPD Candidate RPL554     6/21/2016
GlaxoSmithKline (GSK) Eyes Lead in Triple Lung Drug Market with Early 2016 Filing Plan     6/2/2016
After Initial Miss, GlaxoSmithKline (GSK)'s Pioneering Lung Study Shows Positive Results     5/24/2016
AstraZeneca PLC (AZN) Snaps Up All Rights to Orexo (ORXOF)'s OX-CLI Project     3/17/2016
Investors Hold Their Breath for Data from Aduro Biotech (ADRO), Novartis AG (NVS)     3/11/2016
FDA Approves Novartis AG (NVS)'s Dual Combination Bronchodilator for COPD     10/30/2015
Boehringer Ingelheim and BioMed X Establish Team of Scientists for IDing Key Epigenetic Regulators of COPD     9/21/2015
GlaxoSmithKline (GSK), Theravance (THRX)'s Breo Fails to Extend Lives in Ambitious Study     9/10/2015
AstraZeneca PLC (AZN) Two-in-One Lung Drug Succeeds in Phase III Trial     3/19/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Mylan (MYL), Theravance Biopharma (TBPH) Partner Up for $265 Million COPD Pact     2/2/2015

News from Around the Web
3M Drug Delivery Systems Designs An "Intelligent Inhaler" System For COPD, Asthma And Other Respiratory Ills     4/26/2016
New Links Between Lung Disease And Smoking Behavior Discovered, University of Nottingham Reveals     9/29/2015
Tai Chi Linked To Improved Physical Capacity In Certain Common Long Term Conditions, BMJ Reveals     9/18/2015
The Scripps Research Institute Scientists Create Mimic Of "Good" Cholesterol To Fight Heart Disease And Stroke     10/10/2014
Long-Term Use of Vitamin E May Cut COPD Risk, Cornell University and Brigham and Women's Hospital Study Finds     6/16/2011
Certain COPD Meds Linked to Urinary Troubles in Men, St. Michael's Hospital Study     5/24/2011
Chinese Herbal Paste May Help Prevent Exacerbations of COPD, Gunag'anmen Hospital Study     5/23/2011
Vitamin D Improves Exercise Outcomes in Patients with COPD, Katholieke Universiteit Leuven Study Shows     5/16/2011
Inhaled Meds May Save COPD/Pneumonia Patients' Lives, Veterans Evidence Study     4/21/2011
Spiriva Beats Serevent for COPD Flare-ups, University Hospital Giessen and Marburg GmbH Study     3/24/2011
Airway Mucus Buster, Amygdala Size Matters, University of Texas Study     1/3/2011
Team Treatment Helps Depression, Chronic Disease, University of Washington Study     12/30/2010
Once-a-Day Beta Agonist Works in COPD, Clinical Research Study Finds     11/3/2010
Early Antibiotic Treatment for Severe COPD Symptoms Linked With Improved Outcomes, Baystate Medical Center Study     5/26/2010
Beta-Blockers May Benefit COPD, University Medical Center Utrecht Study     5/25/2010

Press Releases
Theravance Biopharma (TBPH) Highlights Positive Headline Results From IMPACT Study Of Trelegy Ellipta Announced By GlaxoSmithKline (GSK) And Innoviva Inc. (THRX)     9/21/2017
Propeller Health Presents Data On Asthma And COPD At The European Respiratory Society International Congress     9/20/2017
Pulmatrix (PULM) Receives Key Patents On Its Inhaled Drug Delivery Technology And Its COPD Drug     9/20/2017
Theravance Biopharma (TBPH) Highlights Approval Of Trelegy Ellipta (Closed Triple) As The First Once-Daily Single Inhaler Triple Therapy For The Treatment Of Appropriate Patients With COPD In The U.S.     9/19/2017
GlaxoSmithKline (GSK) Investors Rejoice After Winning A Much-Needed OK For Triple COPD Drug Inhaler     9/19/2017
GlaxoSmithKline (GSK) Eyes Regulatory Filings With Mixed Phase III COPD Data     9/12/2017
ProterixBio Presents COPD Clinical Study Results At The European Respiratory Society International Congress     9/12/2017
VIDA Diagnostics Enriches Pulmonary Suite To Include Advanced COPD And Asthma Analysis     9/11/2017
Verona Pharma (VRP.L) Announces Positive Top-Line Data From Phase IIa Clinical Trial In COPD With RPL554 Dosed In Addition To Tiotropium (Spiriva)     9/7/2017
Bellerophon Therapeutics (BLPH) Announces Positive Top Line Phase II Data Of INOpulse For Treatment Of Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease     9/5/2017
Verona Pharma (VRP.L) Doses First Patients In Phase IIb Clinical Trial Of RPL554 For COPD Maintenance Treatment     7/26/2017
Theravance Biopharma (TBPH) AndMylan (MYL) Announce Positive Results From 12-Month Phase III Safety Study Of Revefenacin (TD-4208) In Patients With Chronic Obstructive Pulmonary Disease (COPD)     7/20/2017
Royal Philips Electronics N.V. (PHG)-Sponsored Study Suggests Positive Airway Pressure Therapy Could Reduce COPD Patient Hospitalization     7/10/2017
Cannabis Science Invests In The Research And Development Of Cannabinoid-Based Medications To Treat COPD And Asthma     6/27/2017
Verona Pharma (VRP.L) Receives Regulatory Approval To Commence Phase IIb Clinical Trial Of RPL554 For COPD Maintenance Treatment In Five Countries Across Europe     6/26/2017